These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 15486983)
1. ApcMin/+ mouse model of colon cancer: gene expression profiling in tumors. Leclerc D; Deng L; Trasler J; Rozen R J Cell Biochem; 2004 Dec; 93(6):1242-54. PubMed ID: 15486983 [TBL] [Abstract][Full Text] [Related]
2. Transcriptional profiling of the transition from normal intestinal epithelia to adenomas and carcinomas in the APCMin/+ mouse. Paoni NF; Feldman MW; Gutierrez LS; Ploplis VA; Castellino FJ Physiol Genomics; 2003 Nov; 15(3):228-35. PubMed ID: 13130079 [TBL] [Abstract][Full Text] [Related]
3. Transcriptional profiles of intestinal tumors in Apc(Min) mice are unique from those of embryonic intestine and identify novel gene targets dysregulated in human colorectal tumors. Reichling T; Goss KH; Carson DJ; Holdcraft RW; Ley-Ebert C; Witte D; Aronow BJ; Groden J Cancer Res; 2005 Jan; 65(1):166-76. PubMed ID: 15665292 [TBL] [Abstract][Full Text] [Related]
4. Dietary induction of colonic tumors in a mouse model of sporadic colon cancer. Yang K; Kurihara N; Fan K; Newmark H; Rigas B; Bancroft L; Corner G; Livote E; Lesser M; Edelmann W; Velcich A; Lipkin M; Augenlicht L Cancer Res; 2008 Oct; 68(19):7803-10. PubMed ID: 18829535 [TBL] [Abstract][Full Text] [Related]
5. Dietary-induced ERbeta upregulation counteracts intestinal neoplasia development in intact male ApcMin/+ mice. Barone M; Tanzi S; Lofano K; Scavo MP; Pricci M; Demarinis L; Papagni S; Guido R; Maiorano E; Ingravallo G; Comelli MC; Francavilla A; Di Leo A Carcinogenesis; 2010 Feb; 31(2):269-74. PubMed ID: 19945967 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of intestinal polyposis with reduced angiogenesis in ApcMin/+ mice due to decreases in c-Myc expression. Yekkala K; Baudino TA Mol Cancer Res; 2007 Dec; 5(12):1296-303. PubMed ID: 18171987 [TBL] [Abstract][Full Text] [Related]
7. Genetic signatures of high- and low-risk aberrant crypt foci in a mouse model of sporadic colon cancer. Nambiar PR; Nakanishi M; Gupta R; Cheung E; Firouzi A; Ma XJ; Flynn C; Dong M; Guda K; Levine J; Raja R; Achenie L; Rosenberg DW Cancer Res; 2004 Sep; 64(18):6394-401. PubMed ID: 15374946 [TBL] [Abstract][Full Text] [Related]
8. Detection of metabolic alterations in non-tumor gastrointestinal tissue of the Apc(Min/+) mouse by (1)H MAS NMR spectroscopy. Backshall A; Alferez D; Teichert F; Wilson ID; Wilkinson RW; Goodlad RA; Keun HC J Proteome Res; 2009 Mar; 8(3):1423-30. PubMed ID: 19159281 [TBL] [Abstract][Full Text] [Related]
9. Intestinal immune responses in wild-type and Apcmin/+ mouse, a model for colon cancer. Kettunen HL; Kettunen AS; Rautonen NE Cancer Res; 2003 Aug; 63(16):5136-42. PubMed ID: 12941845 [TBL] [Abstract][Full Text] [Related]
10. Deletion of the WNT target and cancer stem cell marker CD44 in Apc(Min/+) mice attenuates intestinal tumorigenesis. Zeilstra J; Joosten SP; Dokter M; Verwiel E; Spaargaren M; Pals ST Cancer Res; 2008 May; 68(10):3655-61. PubMed ID: 18483247 [TBL] [Abstract][Full Text] [Related]
11. SND1, a component of RNA-induced silencing complex, is up-regulated in human colon cancers and implicated in early stage colon carcinogenesis. Tsuchiya N; Ochiai M; Nakashima K; Ubagai T; Sugimura T; Nakagama H Cancer Res; 2007 Oct; 67(19):9568-76. PubMed ID: 17909068 [TBL] [Abstract][Full Text] [Related]
13. Gene expression profile of mouse prostate tumors reveals dysregulations in major biological processes and identifies potential murine targets for preclinical development of human prostate cancer therapy. Haram KM; Peltier HJ; Lu B; Bhasin M; Otu HH; Choy B; Regan M; Libermann TA; Latham GJ; Sanda MG; Arredouani MS Prostate; 2008 Oct; 68(14):1517-30. PubMed ID: 18668517 [TBL] [Abstract][Full Text] [Related]
14. Wnt inhibitory factor-1: a candidate for a new player in tumorigenesis of intestinal epithelial cells. Cebrat M; Strzadala L; Kisielow P Cancer Lett; 2004 Mar; 206(1):107-13. PubMed ID: 15019166 [TBL] [Abstract][Full Text] [Related]
15. A comprehensive strategy to combat colon cancer targeting the adenomatous polyposis coli tumor suppressor gene. Gerner EW; Ignatenko NA; Lance P; Hurley LH Ann N Y Acad Sci; 2005 Nov; 1059():97-105. PubMed ID: 16382048 [TBL] [Abstract][Full Text] [Related]
16. Alteration of gene expression in normal-appearing colon mucosa of APC(min) mice and human cancer patients. Chen LC; Hao CY; Chiu YS; Wong P; Melnick JS; Brotman M; Moretto J; Mendes F; Smith AP; Bennington JL; Moore D; Lee NM Cancer Res; 2004 May; 64(10):3694-700. PubMed ID: 15150130 [TBL] [Abstract][Full Text] [Related]
17. The receptor tyrosine kinase EPHB4 has tumor suppressor activities in intestinal tumorigenesis. Dopeso H; Mateo-Lozano S; Mazzolini R; Rodrigues P; Lagares-Tena L; Ceron J; Romero J; Esteves M; Landolfi S; Hernández-Losa J; Castaño J; Wilson AJ; Ramon y Cajal S; Mariadason JM; Schwartz S; Arango D Cancer Res; 2009 Sep; 69(18):7430-8. PubMed ID: 19738063 [TBL] [Abstract][Full Text] [Related]
18. Cyclooxygenase-2 inhibitors down-regulate osteopontin and Nr4A2-new therapeutic targets for colorectal cancers. Zagani R; Hamzaoui N; Cacheux W; de Reyniès A; Terris B; Chaussade S; Romagnolo B; Perret C; Lamarque D Gastroenterology; 2009 Oct; 137(4):1358-66.e1-3. PubMed ID: 19549529 [TBL] [Abstract][Full Text] [Related]
19. Identification and classification of differentially expressed genes in non-small cell lung cancer by expression profiling on a global human 59.620-element oligonucleotide array. Hofmann HS; Bartling B; Simm A; Murray R; Aziz N; Hansen G; Silber RE; Burdach S Oncol Rep; 2006 Sep; 16(3):587-95. PubMed ID: 16865260 [TBL] [Abstract][Full Text] [Related]
20. The APC tumor suppressor is required for epithelial integrity in the mouse mammary gland. Prosperi JR; Becher KR; Willson TA; Collins MH; Witte DP; Goss KH J Cell Physiol; 2009 Aug; 220(2):319-31. PubMed ID: 19326388 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]